Literature DB >> 3084905

Left-sided endocarditis due to Pseudomonas aeruginosa. A report of 10 cases and review of the literature.

M Wieland, M M Lederman, C Kline-King, T F Keys, P I Lerner, S N Bass, R Chmielewski, V D Banks, J J Ellner.   

Abstract

Ten confirmed cases of left-sided endocarditis due to Pseudomonas aeruginosa were reported in detail and the English literature was reviewed. In recent years, venous access (usually illicit) has been the major predisposing factor to this infection and abuse of pentazocine and tripelennamine has been particularly associated with endocarditis due to this organism. This infection involves previously damaged as well as normal valves. The development of congestive heart failure did not adversely affect the prognosis of this infection. However, the development of azotemia was associated with a greater likelihood of a fatal outcome. In the current series, deaths were due to uncontrolled infection. This often occurred despite inhibitory and bactericidal activity in serum generally considered adequate for treatment of endocarditis. Medical treatment alone rarely produced cure of infection. Our experience with a high frequency of major vessel embolization (4/10) and the improved survival after medical/surgical treatment suggests that prompt valve replacement combined with high doses of an aminoglycoside plus carbenicillin or ticarcillin provide the best opportunity for successful outcome in patients with left-sided endocarditis due to P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3084905     DOI: 10.1097/00005792-198605000-00006

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  8 in total

1.  [S2 Guideline for diagnosis and therapy of infectious endocarditis].

Authors:  C K Naber
Journal:  Z Kardiol       Date:  2004-12

Review 2.  Antimicrobial agent therapy for Pseudomonas aeruginosa.

Authors:  J A Korvick; V L Yu
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

3.  Gram-negative endocarditis.

Authors:  Milagros P Reyes; Katherine C Reyes
Journal:  Curr Infect Dis Rep       Date:  2008-07       Impact factor: 3.725

Review 4.  Acute infective endocarditis.

Authors:  Jay R McDonald
Journal:  Infect Dis Clin North Am       Date:  2009-09       Impact factor: 5.982

5.  Risk Factors and Outcomes of Endocarditis Due to Non-HACEK Gram-Negative Bacilli: Data from the Prospective Multicenter Italian Endocarditis Study Cohort.

Authors:  Marco Falcone; Giusy Tiseo; Emanuele Durante-Mangoni; Veronica Ravasio; Francesco Barbaro; Maria Paola Ursi; Maria Bruna Pasticci; Matteo Bassetti; Paolo Grossi; Mario Venditti; Marco Rizzi
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

6.  Efficacy of ceftazidime and aztreonam alone or in combination with amikacin in experimental left-sided Pseudomonas aeruginosa endocarditis.

Authors:  A Pefanis; H Giamarellou; P Karayiannakos; I Donta
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

7.  An Unusual Case of Early Onset Persistent Escherichia coli Septicemia Associated with Endocarditis.

Authors:  Sachin K Gupta; Vishakha Nanda; Prashant Malviya; Norman Jacobs; Z Naheed; Tessy Joseph
Journal:  AJP Rep       Date:  2013-07-11

8.  Epidemiology and outcomes of non-HACEK infective endocarditis in the southeast United States.

Authors:  Michael P Veve; Eric D McCurry; Grace E Cooksey; Mahmoud A Shorman
Journal:  PLoS One       Date:  2020-03-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.